Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor
Tyrosine kinase inhibitors in preclinical development
Protein kinase C targeting in antineoplastic treatment strategies
Farnesyl protein transferase inhibitors and other therapies targeting the Ras signal transduction pathway
Epidermal growth factor receptor inhibition in cancer therapy : biology, rationale and preliminary clinical results
Antiandrogens in prostate cancer
Antiestrogens – tamoxifen, SERMs and beyond
Flavopiridol : the first cyclin-dependent kinase inhibitor in human clinical trials
Conference announcement